Skip to Content

· Inside NuMotion 360°       ·Molecular Science ​ ·​Joint Nutrition

From Native Collagen

to Purposeful Peptides.


NuMotion 360° is formulated with FORTIGEL® Bioactive Collagen Peptides®, an ingredient developed for joint-health nutrition. This journal follows the ingredient from native collagen to its studied peptide composition.



EVIDENCE-AWARE GUIDE ​ ​ ​INGREDIENT- SPECIFIC RESEARCH 

CONTROLLED ENZYMATIC HYDROLYSIS               

Stimulates the body’s own mechanisms for maintaining healthy joints and optimum mobility
Promotes joint health naturally 
Scientifically proven to regenerate joint cartilage

· Inside NuMotion 360°     ·Molecular Science     ​ ·​Joint Nutrition

From Native Collagen

to Purposeful Peptides.


NuMotion 360° is formulated with FORTIGEL® Bioactive Collagen Peptides®, an ingredient developed for joint-health nutrition. This journal follows the ingredient from native collagen to its studied peptide composition.


EVIDENCE-AWARE GUIDE ​

INGREDIENT- SPECIFIC RESEARCH

CONTROLLED ENZYMATIC HYDROLYSIS

Stimulates the body’s own mechanisms for maintaining healthy joints and optimum mobility
Promotes joint health naturally 
Scientifically proven to regenerate joint cartilage

Collagen is one of the body’s principal structural proteins. Its triple-helical molecules assemble into fibrils and fibres, helping form the extracellular matrix that gives connective tissues their physical framework.

The analysis describes collagen as accounting for about 30% of total body protein and identifies it as an important component across cartilage, bone, muscle, ligaments, tendons, skin and other connective structures.

01 / NATIVE ARCHITECTURE

The structural protein behind connective tissue.

Collagen is one of the body’s principal structural proteins. Its triple-helical molecules assemble into fibrils and fibres, helping form the extracellular matrix that gives connective tissues their physical framework.

The analysis describes collagen as accounting for about 30% of total body protein and identifies it as an important component across cartilage, bone, muscle, ligaments, tendons, skin and other connective structures.

01 / NATIVE ARCHITECTURE

The structural protein behind connective tissue.


UNDERSTANDING COLLAGEN PEPTIDES

01 / 03

A distinctive amino acid pattern


Structure creates function.

The repeated Gly–X–Y sequence allows three protein chains to pack tightly into collagen’s characteristic helix. Proline and hydroxyproline frequently occupy the X and Y positions and help stabilise this architecture.

02 / 03

Smaller, soluble peptide chains


A different form of the same protein.

Collagen peptides are not intact native collagen. Controlled hydrolysis breaks the original structure into shorter, low-molecular-weight fragments with strong cold-water solubility and non-gelling behaviour.

03 / 03

Designed for nutritional formats


Technical versatility, without heaviness.

The resulting powder can be used in beverages, supplements and functional foods. According to the supplier, it offers a neutral taste and odour, dissolves readily and forms clear solutions without dominating other ingredients.

UNDERSTANDING COLLAGEN PEPTIDES

01 / 03

A distinctive amino acid pattern


Structure creates function.

The repeated Gly–X–Y sequence allows three protein chains to pack tightly into collagen’s characteristic helix. Proline and hydroxyproline frequently occupy the X and Y positions and help stabilise this architecture.

02 / 03

Smaller, soluble peptide chains


A different form of the same protein.

Collagen peptides are not intact native collagen. Controlled hydrolysis breaks the original structure into shorter, low-molecular-weight fragments with strong cold-water solubility and non-gelling behaviour.

03 / 03

Designed for nutritional formats


Technical versatility, without heaviness.

The resulting powder can be used in beverages, supplements and functional foods. According to the supplier, it offers a neutral taste and odour, dissolves readily and forms clear solutions without dominating other ingredients.

02/ THE NUMOTION360° INGREDIENT · J O I N T - S P E C I F I C  P E P T I D E  S C I E N C E




Why FORTIGEL® is not simply “generic collagen.”


Bioactive Collagen Peptides® are peptide compositions produced through proprietary, controlled hydrolysis. FORTIGEL® is the supplier’s joint-health ingredient, characterised by a specific peptide fingerprint and investigated in cartilage and activity-related joint studies.

P R O P O S E D  A C T I O N

Cell metabolism + building blocks


Bioactive Collagen Peptides® stimulate connective-tissue cell metabolism together with delivery of collagen-characteristic amino acids.

I N P U T

Specific collagen peptides

Orally consumed peptide mixture with a defined supplier-controlled profile.

AREA OF STUDY

Cartilage matrix

Research has examined outcomes including pain perception, physical function and cartilage composition.

02/ THE NUMOTION360° INGREDIENT 

· J O I N T    - S P E C I F I C  P E P T I D E  S C I E N C E

Why FORTIGEL® is not simply “generic collagen.”

Bioactive Collagen Peptides® are peptide compositions produced through proprietary, controlled hydrolysis. FORTIGEL® is the supplier’s joint-health ingredient, characterised by a specific peptide fingerprint and investigated in cartilage and activity-related joint studies.

P R O P O S E D  A C T I O N

Cell metabolism + building blocks


Bioactive Collagen Peptides® stimulate connective-tissue cell metabolism together with delivery of collagen-characteristic amino acids.

I N P U T

Specific collagen peptides

Orally consumed peptide mixture with a defined supplier-controlled profile.

AREA OF STUDY

Cartilage matrix

Research has examined outcomes including pain perception, physical function and cartilage composition.


0 3 / E V I D E N C E,   R E A D  I N  C O N T E X T

What the cited human studies examined.

Clinical evidence is most useful when the study population, dose, duration and comparator are visible. These summaries reflect studies highlighted in GELITA’s FORTIGEL® technical brochure; they do not guarantee the same outcome for every person or every finished product.

0 3 / E V I D E N C E,   R E A D  I N  C O N T E X T

What the cited human studies examined.

Clinical evidence is most useful when the study population, dose, duration and comparator are visible. These summaries reflect studies highlighted in GELITA’s FORTIGEL® technical brochure; they do not guarantee the same outcome for every person or every finished product.

A randomized, double-blind, placebo-controlled trial reported differences in selected joint-pain assessments favouring collagen hydrolysate. This study examined symptoms, not proof of cartilage regrowth.

Activity-related joint discomfort in athletes


147 ATHLETES  ​ ​10 G DAILY ​ ​ 24 WEEKS


2008

A small randomized pilot used dGEMRIC imaging in people with early knee osteoarthritis. The authors concluded that the method may detect changes in cartilage proteoglycan content after 24 weeks; the exploratory result should not be presented as definitive regeneration.

Pilot cartilage-imaging investigation


30 PARTICIPANTS  ​ ​10 G DAILY ​ ​ 48 WEEKS

2011


Participants aged 18–30 with exercise-related knee discomfort received specific collagen peptides or placebo. The peptide group had a greater reduction in activity-related knee pain scores than placebo.

Knee discomfort in active young adults


180 ADULTS  ​ 5 G DAILY ​ ​ 12 WEEKS

2021


This randomized trial reported significant between-group differences for selected physician- and participant-rated pain and movement outcomes. Results apply to the tested composition and study population.

Everyday knee and hip discomfort


182 ADULTS  ​ 5 G DAILY ​ ​ 12 WEEKS

2024


Study findings describe group averages and do not guarantee individual results. Some collagen-peptide studies include authors or support connected to the ingredient industry; this context should be considered alongside study design, sample size and independent replication.

A randomised, double-blind, placebo-controlled trial reported differences in selected joint-pain assessments favouring collagen hydrolysate. This study examined symptoms, not proof of cartilage regrowth.

Activity-related joint discomfort in athletes


147 ATHLETES        10 g DAILY ​        24 WEEKS


2008

A small randomised pilot used dGEMRIC imaging in people with early knee osteoarthritis. The authors concluded that the method may detect changes in cartilage proteoglycan content after 24 weeks; the exploratory result should not be presented as definitive regeneration.

Pilot cartilage-imaging investigation


30 PARTICIPANTS        10 g DAILY ​        48 WEEKS

2011


Participants aged 18–30 with exercise-related knee discomfort received specific collagen peptides or placebo. The peptide group had a greater reduction in activity-related knee pain scores than placebo.

Knee discomfort in active young adults


180 ADULTS         5 g DAILY ​         12 WEEKS

2021


This randomised trial reported significant between-group differences for selected physician- and participant-rated pain and movement outcomes. Results apply to the tested composition and study population.

Everyday knee and hip discomfort


182 ADULTS         5 g DAILY ​         12 WEEKS

2024


Study findings describe group averages and do not guarantee individual results. Some collagen-peptide studies include authors or support connected to the ingredient industry; this context should be considered alongside study design, sample size and independent replication.

Clinical studies show how hydrolysed collagen peptides support cartilage metabolism, structure and long-term joint health.
Clinical studies show how hydrolysed collagen peptides support cartilage metabolism, structure and long-term joint health.

Disclaimers: 
Scientific Reference Note: The clinical research findings, structural data, and functional mechanisms featured on this page are sourced and adapted from GELITA (gelita.com). All referenced trials and peptide evaluations are the intellectual property of their respective originators. 
This page is educational and is not intended to diagnose, treat, cure or prevent disease.

Disclaimers: 
Scientific Reference Note: The clinical research findings, structural data, and functional mechanisms featured on this page are sourced and adapted from GELITA (gelita.com). All referenced trials and peptide evaluations are the intellectual property of their respective originators. 
This page is educational and is not intended to diagnose, treat, cure or prevent disease.